Article: PuriCore Q3 Interim Management Statement.

PuriCore (LSE: PURI), the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today issues an Interim Management Statement covering the three-month and nine-month periods ending September 30, 2009. Financial Results (unaudited) Q3 sales of $10.6 million (2008: $8.4 million), an increase of 25% (35% increase at constant currency)

US Food Safety revenue increased 10% to $5.8 million

UK Endoscopy (including Sterilox business and Labcaire Systems) revenue increased 52% to $4.6 million (78% at ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!